Establishment Labs (ESTA)
(Delayed Data from NSDQ)
$54.37 USD
+0.37 (0.69%)
Updated May 21, 2024 04:00 PM ET
After-Market: $54.34 -0.03 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ESTA 54.37 +0.37(0.69%)
Will ESTA be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ESTA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ESTA
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
ESTA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Lags Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Soars 7.8%: Is Further Upside Left in the Stock?
Other News for ESTA
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)
Establishment Labs Holdings Inc (ESTA) Q1 2024 Earnings: Misses Revenue Estimates
Establishment Labs Holdings Reaches Analyst Target Price
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Cytokinetics (CYTK)
What's Driving Establishment Labs Holdings Inc's Surprising 34% Stock Rally?